Target
cannabinoid CB2 receptors (CB2R)
2 abstracts
Abstract
Effect of TT-816, a novel immune response modifier targeting cannabinoid CB2 receptor, on antitumor immunity and cancer growth.Org: Teon Therapeutics,
Abstract
Quality of pain management in patients with cancer in the outpatient setting.Org: MedStar Union Memorial Hospital, The Ohio State University - James Cancer Hospital, University of Louisville, University of Nebraska Medical Center,